monash university research projects

Help & FAQ

Find Research Projects

Filters for projects.

Search concepts

Selected filters

1 - 50 out of 24,537 results
Status, start date (ascending)
Export search results

Search results

Theory use in social care practice: improving implementation and outcomes.

Australian Research Council (ARC)

5/08/24 → 4/08/27

Project : Research

A Phase 1/1b Open-Label Dose-Escalation Study of Bcl-2 Inhibitor BGB-21447 in Patients With Mature B-Cell Malignancies

1/08/24 → 31/07/29

A Phase 3, 52-week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis (PN) Who are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies

30/07/24 → 29/07/26

A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-4098 Alone and/or in Combination with Azacitidine in Adults with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome/AML (MDS/AML) or Myelodysplastic Syndrome with Excess Blasts (MDS-EB)

29/07/24 → 28/07/29

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VE303 FOR PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION – THE RESTORATIVE303 STUDY

A 26-week, randomized, double-blind, placebo-controlled, multi-center study to evaluate the efficacy, safety, and tolerability of axatilimab in subjects with idiopathic pulmonary fibrosis (ipf), a phase ⅰ/ⅱ, multicenter, open-label study of ibi3004 in subjects with unresectable, locally advanced or metastatic solid tumors.

Frentzas, S.

Evaluating the implementation of a co-designed psychosocial peer support program for young people experiencing mental illness: A pilot study

Savaglio, M. & Skouteris, H.

29/07/24 → 27/07/25

A Phase III, Randomised, Double -Blind, Active-controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants with CKD and High Blood Pressure (ARCTIC)

A phase 3, multi-center, randomized withdrawal and long-term extension study of ampreloxetine for the treatment of symptomatic neurogenic orthostatic hypotension in participants with multiple system atrophy.

Bertram, K.

25/07/24 → 25/07/26

Multi-phase modelling and characterisation of mudrush hazard in cave mining

Karakus, M., Nguyen, G., Bui, H. H. & Chester, C.

25/07/24 → 24/07/28

Smart In-Process Quality Inspection

Tang, Y. & Granland, K.

25/07/24 → 24/04/25

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients with Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease

24/07/24 → 31/08/27

A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTI- CENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO

23/07/24 → 23/07/26

Powder Manufacturing Facility for Additive Manufacturing

Proust, G., Ringer, S., Paradowska, A. M., Ma, Q., Feih, S., Sun, S., An, X., Huang, A. & Fabijanic, D.

23/07/24 → 22/07/25

MonumenTAL-8 - A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants with High-Risk Multiple Myeloma

Spencer, A.

20/07/24 → 20/07/26

A Phase 2, Randomized, Double-blind, Placebo controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma

Gillman, A.

19/07/24 → 18/07/26

A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Imatinib Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Fleming, S.

19/07/24 → 5/12/26

Optimising sleep, alertness and safety in shift work industries

Sletten, T.

18/07/24 → 17/07/27

An Interventional Study to Evaluate Treating to a Target of Transmural Healing in Patients with Moderately to Severely Active Crohn’s Disease (VECTORS)

Sparrow, M.

18/07/24 → 17/07/26

Clinical, laboratory and radiological predictive factors for safety and efficacy of chimeric antigen receptor (CAR) T-cell therapy in Australia: A multi-centre real-world study

16/07/24 → 15/07/26

A Phase 3, Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment with One Nextgeneration Hormonal Agent (NHA)

16/07/24 → 15/07/29

Mandatory Installation of EDRs In Road Vehicles Supplied to the Australian Market

Fitzharris, M. , Logan, D. , Liu, S. , Newstead, S. & Koppel, S.

15/07/24 → 11/11/24

Transforming Auslan education in Australia

Willoughby, L.

15/07/24 → 14/07/27

Adobe Research Gift Fund: Adobe Research Gift Fund

Adobe Systems Incorporated

15/07/24 → 14/07/34

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in Non-Cirrhotic Subjects with Nonalcoholic Steatohepatitis (NASH)

9/07/24 → 8/07/29

A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib with Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects with Moderately to Severely Active Crohn’s Disease and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy

Cambria-2: a phase iii, open-label, randomised study to assess the efficacy and safety of camizestrant (azd9833, a next-generation, oral selective estrogen receptor degrader) versus standard endocrine therapy (aromatase inhibitor or tamoxifen) as adjuvant treatment for patients with er+/her2- early breast cancer and an intermediate-high or high risk of recurrence who have completed definitive locoregional treatment and have no evidence of disease.

McCartney, A.

2024 Early Childhood Professional Learning Program on Managing Inclusive Classrooms in Preschool Settings

Adams, M. & Quiñones, G.

8/07/24 → 31/12/24

Molecular insights into the allosteric regulation of opioid receptors

Batista Gondin, A.

6/07/24 → 5/07/27

A Multicenter, Randomized, Double-blind, 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS 1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) Part 1: Placebo-Controlled, Dose-Ranging Study of GS 1427; Part 2: Active-Controlled, Combination Study Evaluating the Efficacy and Safety of GS-1427 in Combination With Ustekinumab versus GS-1427 or Ustekinumab monotherapy

5/07/24 → 4/07/29

An open-label, multi-center, roll-over study for patients who have completed a prior Novartis-sponsored sabatolimab (MBG453) study and are judged by the investigator to benefit from continued treatment with sabatolimab

A phase i/iia multi-center, open-label master protocol to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary antitumor activity of azd8205 in participants with advanced or metastatic solid malignancies.

2/07/24 → 1/07/29

Mercy Health Model of Care

Woolford, M. & Ayton, D.

2/07/24 → 31/03/25

Equity Trustees and Monash Partners 2023 Clinician Fellowship Program

1/07/24 → 1/07/25

Ara-Thulu (tree)

Martin, B. , Gamango, S., Patro, D., Webb, B. & Briggs, C.

1/07/24 → 30/04/26

CSIRO Next Generation: Development of an AI-augmented NDIS coaching planning, content generation and reporting system and its assessment against existing manual best practices

Kuhlmann, L. , Anderson, D. & Khurshid, H.

1/07/24 → 30/06/26

Before and after the Last Ice Age: GunaiKurnai archaeology along the Snowy

David, B. , Mullett, R., Green, H., Manne, T., Delannoy, J., Arnold, L. J., Perez, V., Llamas, B., Petchey, F. & Wright, N.

1/07/24 → 30/06/29

ARC Centre of Excellence for Indigenous and Environmental Histories and Futures

Ulm, S., Russell AM, L. , Fletcher, M., Nakata, N., Bird, M., Watkin Lui, F., Crayn, D., Grech, A., McNiven, I. , Prendergast, A., Bradshaw, C. J. A., Wilson, C., Saltre, F., Tobler, R., Stevenson, J., Haberle, S., Sharples, J., Bashford, A., McDonald, J., Veth, P., Turpin, G., Helgen, K., Mate, G., Asmussen, B., Faulkhead, S., Henry, D. A., Treble, P., Gadd, P., Levchenko, V., Leavesley, M. G., Slack, M., Williams, A., Nicholas, G., Crabtree, S. & Chandler, T.

1/07/24 → 1/07/31

Enabling Accessible, Inclusive Playgrounds for Children and Carers with Vision Impairment

Reinhardt, D., Butler, M. , Marriott, K. , Holloway, L., Loke, L., Silveira, S. & Tait, K.

1/07/24 → 30/06/27

FRONTIER-AP: Randomized controlled trial of thrombectomy versus standard medical therapy for stroke with medium sized vessel occlusion: Frontier-AP

Phan, T. , Yan, B., Mitchell, P. J., Ma, H. , Churilov, L., Gao, L., Parsons, M. W., Blackberry, I., Balabanski, A. & Davis, S. M.

Antithrombotic therapy to ameliorate clinical complications in community acquired pneumonia (ATTACC-CAP)

McQuilten, Z. , Tong, S. Y. C., Webb, S. , Higgins, L. , Ryan, L. , Venkatesh, B., Roberts, J. A., Tran, H. , Zarychanski, R., McFadyen, J. , Aung, A. K., Lawler, P. R., Winearls, J. & Burrell, A.

1/07/24 → 30/06/28

Collaboration between a public and a private early parenting centre to improve social disadvantage though continuous quality improvement

Fisher, J. , Stanzel, K. , Dwyer, A., Tran, T. , Nguyen, H. & Thean, P.

The impact of EMS agency factors and resuscitation practice on out-of-hospital cardiac arrest outcomes across Australia and New Zealand

Bray, J. , Howell, S. & Ball, S. J.

1/07/24 → 31/12/24

The Politics of Marriage in the Japanese Empire: Competing Discourses on the Marital Family in Colonial Korea, Taiwan and the Metropole

Darby, A. & Jackson, A.

Korea Foundation

Taxonomy of the skink genus Lerista (Scincidae) in Western Australia

Chapple, D. , Farquhar, J., Rabosky, D. L. & Doughty, P.

Monash University – Internal School Contribution , Monash University , Western Australian Museum (trading as WA Museum Boola Bardip) , University of Michigan